Immunoglobulins in the treatment of Guillain-Barre Syndrome

被引:0
作者
Kloss, TM [1 ]
Haupt, WF [1 ]
机构
[1] UNIV COLOGNE,KLIN & POLIKLIN NEUROL & PSYCHIAT,W-5000 COLOGNE,GERMANY
关键词
D O I
10.1055/s-2007-1017831
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Treatment of acute Guillain-Barre syndrome (GBS) comprises the best standard of intensive care on one hand and immunomodulatory treatments on the other. Two multicenter trials have established the value of plasma exchange therapy to shorten the clinical course of acute GBS. A further study revealed equal results with plasma exchange and intravenous immunoglobulin (IvIG) treatment. The mode of action of IvIG is unknown, the effect may be in part due to HLA-and CD-4-molecules contained in variable concentrations in the various preparations. Since the preparation procedures vary considerably, one cannot a priori assume equal efficacy of all products. Treatment by IvIG offers numerous logistic and technical advantages, however, a number of adverse effects in the form of myocardial infarction, stroke, renal failure, and hepatitis C infections have been reported. The current multicenter trials on the treatment of acute GBS will provide more detailed information on the value of IvIG treatment.
引用
收藏
页码:36 / 41
页数:8
相关论文
共 55 条
  • [1] ANDERSSON UG, 1993, IMMUNOLOGY, V79, P211
  • [2] [Anonymous], 1990, GUILLAIN BARRE SYNDR
  • [3] SOLUBLE CD4, CD8, AND HLA MOLECULES IN COMMERCIAL IMMUNOGLOBULIN PREPARATIONS
    BLASCZYK, R
    WESTHOFF, U
    GROSSEWILDE, H
    [J]. LANCET, 1993, 341 (8848) : 789 - 790
  • [4] TRANSMISSION OF VIRAL-INFECTION BY PREPARATIONS OF INTRAVENOUS IMMUNOGLOBULIN
    BUSSEL, J
    CUNNINGHAMRUNDLES, C
    FELDMAN, C
    HOROWITZ, B
    [J]. PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1988, 9 (02): : 193 - 205
  • [5] HUMAN IMMUNE GLOBULIN INFUSION IN GUILLAIN-BARRE-SYNDROME - WORSENING DURING AND AFTER TREATMENT
    CASTRO, LHM
    ROPPER, AH
    [J]. NEUROLOGY, 1993, 43 (05) : 1034 - 1036
  • [6] CONTANTINESCU CS, 1993, NEW ENGL J MED, V329, P583
  • [7] ANTIGEN ANALOG MAJOR HISTOCOMPATIBILITY COMPLEXES ACT AS ANTAGONISTS OF THE T-CELL RECEPTOR
    DEMAGISTRIS, MT
    ALEXANDER, J
    COGGESHALL, M
    ALTMAN, A
    GAETA, FCA
    GREY, HM
    SETTE, A
    [J]. CELL, 1992, 68 (04) : 625 - 634
  • [8] DWYER JM, 1992, NEW ENGL J MED, V326, P107
  • [9] ELLIE E, 1992, NEW ENGL J MED, V327, P1032
  • [10] ERNERUDH J, 1990, ACTA NEUROL SCAND, V82, P284